Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome
Patients with HB, and potentially HCC, who are ineligible for COG trials are primarily patients with an oxygen requirement and/or renal insufficiency, often associated with preexisting congenital conditions. Such patients would benefit from future studies to improve outcomes.
Authors
- Marcio H. Malogolowkin
- Angela D. Trobaugh‐Lotrario (ORCID: https://orcid.org/0000-0002-2668-7686)
- Greg Tiao (ORCID: https://orcid.org/0000-0001-8099-2596)
- Allison F. O’Neill (ORCID: https://orcid.org/0000-0002-8957-3870)
- James I. Geller (ORCID: https://orcid.org/0000-0001-5181-116X)
- Katelyn A. Belmonte
Institutions
- Providence Sacred Heart Medical Center (US)
- Cincinnati Children's Hospital Medical Center (US)
- Boston Children's Hospital (US)
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- University of California, Davis (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1002/pbc.31389
- Citations
- 3
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 3.33